Sernova Corp. (TSE:SVA – Get Free Report) shares traded down 1.5% on Thursday . The company traded as low as C$0.32 and last traded at C$0.34. 182,500 shares changed hands during trading, an increase of 17% from the average session volume of 156,507 shares. The stock had previously closed at C$0.34.
Analyst Upgrades and Downgrades
Separately, Raymond James set a C$1.50 price target on shares of Sernova and gave the company a “market perform” rating in a research note on Thursday, April 4th.
Check Out Our Latest Stock Report on SVA
Sernova Trading Down 1.5 %
About Sernova
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
Read More
- Five stocks we like better than Sernova
- What is a Secondary Public Offering? What Investors Need to Know
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Are Penny Stocks a Good Fit for Your Portfolio?
- AbbVie Stock: A Perfect Dip for Investors to Buy
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.